1 / 48

Nursing Care and Interventions with Diseases of the Liver, Gallbladder & Pancreas

Nursing Care and Interventions with Diseases of the Liver, Gallbladder & Pancreas. Keith Rischer RN, MA, CEN. Today’s Objectives…. Review pathophysiology and systemic manifestations of the inflammatory response.

Download Presentation

Nursing Care and Interventions with Diseases of the Liver, Gallbladder & Pancreas

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Nursing Care and Interventions with Diseases of the Liver, Gallbladder & Pancreas Keith Rischer RN, MA, CEN

  2. Today’s Objectives… • Review pathophysiology and systemic manifestations of the inflammatory response. • Compare and contrast pathophysiology & manifestations of diseases of the liver, pancreas and gallbladder. • Interpret abnormal laboratory test indicators of liver, pancreatic and gallbladder function. • Identify the diagnostic tests, nursing priorities, and client education with diseases of the liver, pancreas and gallbladder. • Analyze assessment data from clients with cirrhosis to determine nursing diagnoses and formulate a plan of care for clients with diseases of the liver, pancreas and gallbladder. • Prioritize assessment based nursing care for clients experiencing chronic pancreatic or gall bladder disease. • Integrate nutrition therapy in care of clients with hepatic, pancreatic or gallbladder disease.

  3. Inflammatory Response • Occurs in response to injury • Localized • Immediate • Beneficial • Appropriate level of response • Non Specific

  4. What is a Mast Cell? • Bag of Granules • Located in connective tissue • close to blood vessels • Histamine released • Increase blood flow • Increase vascular permeability • Binds to H1, H2 receptors

  5. Causes • Bacteria-viral • Trauma • Lacerations • Allergic response • Bites • Burns

  6. Purpose of inflammation • Neutralizes and Dilutes Toxins • Removes necrotic materials • Provides an environment for healing

  7. Systemic Manifestations of Acute Inflammation • Fever/chills • Benefits • Increased killing of microorganisms • Increased phagocytosis by neutrophils • Increased activity of interferon • Leukocytosis • Plasma Proteins

  8. Patho Review • Liver • Produces bile…elimination of bilirubin • Drug/hormone metabolism • CHO-fat-protein metabolism • Clotting factor synthesis • Storage of vitamins & minerals • Gallbladder • Store & concentrate bile • Pancreas • Endocrine • Exocrine

  9. Hepatitis Definition: • Inflammation of the Liver Causes: • Viral (most common) • A, B, C, D, E • Toxic • Amiodorone, Tylenol, statins • Alcohol

  10. Hepatitis A THINK FECAL-ORAL Etiology: Hepatitis A Virus • Incubation period: 15-50 days • Duration: 60 days • Young children asymptomatic • No chronic carrier…virus in feces during incubation pd. Before sx apparent Transmission: Fecal-Oral • Outbreaks occur by contaminated food/drinking water • Male homosexuals • Poor hygiene, improper handling of food, poor sanitary conditions • HAV found in feces 2 or more weeks before onset of sx and up to one week after onset of jaundice

  11. Hepatitis A: Prevention • Good hygiene • Water treatment • Hepatitis A vaccine • booster 6-12 mos after first dose • Immunoglobulin before exposure or within 2 weeks after exposure • protects about 2 months

  12. Hepatitis B THINK BODY SECRETIONS-BLOOD Etiology: Hepatitis B Virus • Incubation period: 48-180 days (mean 56-96) • Chronic & carrier status Transmission • Exposure to infected blood, blood products or body fluids • Found in most body secretions • Perinatal: mother to baby (10-85% liklihood) • 90% become chronic carrier…25% mortality as adults • Percutaneously (IV drug use, needle sticks) • Nurses at risk! • STD-30% cases r/t heterosexual activity • Major source of spread are healthy, chronic carriers

  13. Hepatitis B: Prevention Hepatitis B vaccine • series of 3; use of HBIG for post-exposure prophylaxis • Screening of donor blood • Use of disposable equipment • Sterilization of non-disposable equipment • Abstinence/condom use • Needle exchange programs • Use of standard precautions and PPE

  14. Hepatitis C THINK BLOOD-IV DRUG USE Etiology: Hepatitis C Virus • Incubation period: 14-180 days (mean 56) • Sx persist 2-12 weeks • Most common cause of chronic hepatitis, cirrhosis, liver CA • Most are asymptomatic carriers-spread to others Transmission • Percutaneous-contaminated needles • Bloodborne pathogen • Before 1990 most cases due to contaminated blood • IV drug use, needle sticks (tattoo/body piercing) • Perinatal/sexual contact uncertain

  15. Hepatitis C:Prevention • Screening of donor blood • Use of disposable equipment • Sterilization of non-disposable equipment • Abstinence/condom use • No vaccine or use of IG at this time

  16. Chronic Hepatitis Responsible for most cases of cirrhosis, liver CA • HCV responsible for 80% cases • Smolders over years…silently destroying liver cells Most asymptomatic but then develop… • Malaise • Easy fatigability • Jaundice • Hepatomegaly

  17. Hepatitis-Cirrhosis: Laboratory Assessment • AST-Aspartate aminotransferase • ALT-Alanine aminotransferase • ALP-Alkaline Phosphatase • Total bilirubin • Albumin • Ammonia • INR-Prothrombin time (PT)

  18. Hepatitis-Cirrhosis: Early Clinical Manifestations • Fatigue • Significant change in weight • Gastrointestinal symptoms • Abdominal pain and liver tenderness • Pruritus

  19. Hepatitis-Cirrhosis: Late Clinical Manifestations • Jaundice and icterus • Dry skin • Rashes • Petechiae, or ecchymoses (lesions) • Peripheral dependent edema of the extremities and sacrum

  20. Hepatitis: Endstage Complications • Mortality 1% • Higher w/elderly & other underlying debilitating disease • Hepatic failure • Ascites • Chronic hepatitis • Cirrhosis • Hepatic cancer • Liver transplant

  21. Hepatitis: Care Planning Priorities • Fatigue • Physical rest • Nutritional intake • Sm. Frequent meals • High carb-low fat • Nausea • Knowledge deficit • Avoid Tylenol, ETOH • Diet • Drug therapy • Interferon: SQ and po

  22. Cirrhosis • Patho • Inflammation • Causes • ETOH • Hepatitis C

  23. Cirrhosis: Physical Assessment • Massive ascites • Hepatomegaly (liver enlargement) • Assess nasogastric drainage, vomitus, and stool for presence of blood • Bruising, petechiae, enlarged spleen • Neurologic changes

  24. Complications: Cirrhosis • Portal hypertension • Ascites • Bleeding esophageal varices • Coagulation defects • Vitamin K not absorbed • Jaundice • Primary liver disease • Intra-hepatic obstruction • Portal-systemic encephalopathy with hepatic coma • Ammonia levels • lactulose

  25. Cirrhosis: Care Planning Priorities • Excess fluid volume • Diuretics • Low sodium diet • Paracentesis • Risk for imbalanced nutrition • Chronic pain • Risk for impaired skin integrity • Potential for hemorrhage

  26. Cirrhosis: Nursing Priorities • Fluid-electrolyte management • Na+, K+, BUN, • I&O • Bleeding precautions • Assess INR-PT-platelet-Hgb • Monitor ortho’s • Assess sx bleeding • Neurologic assessment/monitoring • Assess ammonia levels • Monitor LOC/orientation • Fall risk

  27. Liver Case Study • 67yr male • PMH: DMII, ETOH abuse, high cholesterol, PAF, CRI, Kidney CA 2001, cardiomyopathy • CC: painless jaundice that started appx 4 weeks ago when wife noted eyes becoming yellow…did not seek medical care right away • Became visibly jaundiced, developed dark urine, stools light in color, weak but no N-V-D or abd pain • MD office: Bili of 25. Amiodorone and Lipitor DC’d. US abd done • Hepatic duct dilation w/further testing found to have pancreatic mass

  28. Liver Case Study • VS: T-97.8 P-65 R-20 BP-90/37 sats 96% 2l n/c • BMI 33.6 • Dx: • CXR: cardiomegaly, pulmonary vascular congestion, mild CHF • Assessment: • Conjuctival icterus, as well as skin • Bibasilar crackles • CV-no edema • GI:abd distended, BS present • Neuro: oriented x3 but lethargic

  29. Labs

  30. Liver Case Study • Nursing Priorities… • Medical Priorities… • GI • Pancreatic malignancy • Hepatitis/cirrhotic liver • CV • Hypotension • AFib • Dilated cardiomyopathy

  31. Acute Cholecystitis-Cholelithiasis • Incidence/Prevalence • 20% US population impacted • Risk Factors • Sedentary lifestyle • Obesity • Middle aged Caucasian women • High cholesterol • Estrogen-BCP • Patho • Inflammation • Gallstones • Cholesterol/bile salts • Cystic duct obstruction or may lie dormant in GB

  32. Acute Cholecystitis-Cholelithiasis:Clinical Manifestations (chart 63-1 p.1398) • Upper abd. pain • RUQ or epigastric • Rebound tenderness • Episodic or vague • Radiation to right shoulder • Triggered by high fat/large meal • Anorexia • N&V • Fever

  33. Acute Cholecystitis-Cholelithiasis Diagnostic & Interventions • Laboratory Findings • WBC • Diagnosis • CT or US • Interventions • Nonsurgical • Diet • Pharmocological • Surgical • laparoscopic

  34. Acute Cholecystitis-Cholelithiasis: Nursing Priorities • Acute pain • Impaired skin integrity • Risk of infection • Knowledge deficit • Pain management • Diet therapy • Low-fat • Smaller, more frequent meals • Wound/incision care • Signs of infection • Activity restrictions • Follow-up care

  35. Acute Pancreatitis • Pancreas • Functions as both exocrine/endocrine gland • Patho • Lipolysis • Proteolysis • Necrosis of blood vessels • Inflammation • Theories of enzyme activation • ETOH

  36. Pancreatitis: Etiology • Biliary obstruction • Cholecystectomy-postop • Trauma • Familial/genetic • Incidence/Prevalence • ETOH-holidays • Women-after cholelithiasis • Mortality • 10% • Higher w/elderly & postop

  37. Pancreatitis:Physical Assessment • Abdominal pain-LUQ/epigastric • Radiation to back, left flank/shoulder • Nursing Assessment • Abdomen • Respiratory • Neuro • VS

  38. Pancreatitis:Laboratory/Diagnostic Assessment • Lab • Amylase • Lipase • Glucose • Bilirubin • WBC • Radiographic • CT • MRI

  39. Complications of Acute Pancreatitis p.1404 Table 63-2 • Pancreatic infection • Hemorrhage • Hypovolemic or septic shock • Respiratory • Pleural effusion • Pneumonia • Acute Resp. Distress Syndrome (ARDS) • Multisystem organ failure • Disseminated intravascular coagulation • Diabetes mellitus

  40. Pancreatitis: Nursing Priorities • Acute Pain • PCA • Imbalanced nutrition • Nothing by mouth in early stages-7-10 days • Antiemetics for nausea and vomiting • Total parenteral nutrition • Small, frequent, moderate to high-carbohydrate, high-protein, low-fat meals • Knowledge deficit • ETOH avoidance • Recurrent abd pain • Jaundice-clay colored stools-darkened urine

  41. Pancreatic Carcinoma • Etiology • Smoking • Elderly 60-80 years • Genetic • Patho • Primary vs. metastatic • Aggressive mets

  42. Case Study • 22 year old female presents to the ED for c/o fatigue, N&V and feeling worn out the last several days with dark urine • Meds-BCP • VS: T-100.7 P-102 R-20 BP-110/74 sats 98% • Assessment • Mucous membranes tacky/dry • Generalized abd pain w/tenderness in RUQ

  43. WBC: 8.8 Hgb: 12.9 Platelets: 125 Neutrophil: 29% Lymphocytes: 64% Na-132 K-3.7 Creatinine-0.67 Urine preg-neg Heterophile-positive Total bili-4.1 Alk. Phos-389 ALT-199 AST-127 UA Urobili-increased Protein-neg Glucose-neg Ketones-mod Bilirubin-abnormal Blood-mod Nitrite-neg LET-negative WBC-neg Bacteria-3 Case Study: cont.

  44. Case Study: cont. • Nursing priorities… • Nursing Interventions…

  45. 40 yr male w/seizure disorder Chief complaint Altered mental status Vague abd pain Weakness Hypotension Admission Labs WBC-11,000 Hgb-12.2 Platelets-64,000 Creatinine-2.7 ALT-502 AST-219 Ammonia-68 Lipase-1947 Glucose-322 CT Case Study

  46. Case Study:Later… Day of Admission • Increasing lethargy, resp. distress • ABG • pH- 7.38 • CO2- 40 • O2- 52 • HCO3- 23 • O2 sats- 84 • FiO2-100% vent…AC12, PEEP +5

  47. CVP-21 VS-101.2-118-24-82/40 Labs WBC-12.7 Platelets-56 Creatinine-.7 ALT-243 AST-219 Lipase 523 ABG pH-7.25 CO2-52 O2-76 O2 sats-92% FiO2-100% PEEP now +10 Weight up 8 kg Non icteric IV Infusions Insulin gtt Lasix gtt TPN-Lipids Fentanyl gtt Versed gtt Levophed gtt Neosynephrine gtt Vasopressin gtt Heparin gtt Case Study:Day 1

  48. CVP-16 –weight up another 7.5 kg…poor u/o VS-100.5-110-24-84/44 Labs WBC-21.5 Hgb-12.5 Platelets-77 Creatinine-0.9 ALT-143 AST-41 Ammonia-30 Lipase 114 ABG pH-7.11 CO2-78 O2-58 HCO3-24 O2 sats-75% Vent-FiO2-100%, +15 Treatment Plan CRRT IV abx-Cipro/Flagyl Hold Lasix gtt NG LCS Lactulose Wean vasoactive gtts as able Continue all previous gtts Pan cultures Nursing Priorities Case Study:Day 2

More Related